• 1. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 2. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

Recent Advances in the Study of 4-amino-2-(methylsulfanyl)pyrimidine-5-carbaldehyde (CAS: 770-31-0)

4-amino-2-(methylsulfanyl)pyrimidine-5-carbaldehyde (CAS: 770-31-0) is a key intermediate in the synthesis of various bioactive compounds, particularly in the field of medicinal chemistry. Recent studies have highlighted its potential as a building block for the development of novel therapeutic agents, including kinase inhibitors and antimicrobial compounds. This research brief aims to provide an overview of the latest advancements related to this compound, focusing on its synthesis, applications, and biological activities.

One of the most significant developments in the study of 4-amino-2-(methylsulfanyl)pyrimidine-5-carbaldehyde is its role in the synthesis of kinase inhibitors. Kinases are critical targets in cancer therapy, and recent research has demonstrated that derivatives of this compound exhibit potent inhibitory activity against specific kinase isoforms. For instance, a 2023 study published in the Journal of Medicinal Chemistry reported the synthesis of a series of pyrimidine-based inhibitors using 4-amino-2-(methylsulfanyl)pyrimidine-5-carbaldehyde as a starting material. These inhibitors showed promising activity against EGFR and HER2 kinases, which are often implicated in various cancers.

In addition to its applications in oncology, 4-amino-2-(methylsulfanyl)pyrimidine-5-carbaldehyde has also been explored for its antimicrobial properties. A recent study in the European Journal of Medicinal Chemistry (2024) investigated the compound's derivatives for their efficacy against drug-resistant bacterial strains. The results indicated that certain modifications to the pyrimidine core could enhance antibacterial activity, particularly against methicillin-resistant Staphylococcus aureus (MRSA). This finding opens new avenues for the development of next-generation antibiotics.

The synthetic pathways for 4-amino-2-(methylsulfanyl)pyrimidine-5-carbaldehyde have also seen advancements. A 2024 publication in Organic Letters described a novel, high-yield method for its synthesis using a one-pot reaction strategy. This approach not only improves the efficiency of production but also reduces the environmental impact by minimizing waste generation. Such innovations are critical for scaling up the production of this compound for industrial and pharmaceutical applications.

Despite these promising developments, challenges remain in the optimization of 4-amino-2-(methylsulfanyl)pyrimidine-5-carbaldehyde derivatives for clinical use. Issues such as bioavailability, toxicity, and selectivity need to be addressed through further research. However, the compound's versatility and the growing body of research supporting its applications suggest a bright future in drug discovery and development.

In conclusion, 4-amino-2-(methylsulfanyl)pyrimidine-5-carbaldehyde (CAS: 770-31-0) continues to be a focal point in medicinal chemistry research. Its role in the synthesis of kinase inhibitors and antimicrobial agents underscores its potential as a valuable scaffold for drug development. Ongoing studies are expected to further elucidate its mechanisms of action and expand its applications in treating various diseases.

• 588-36-3([4-amino-2-(methylsulfanyl)pyrimidin-5-yl]methanol)
• 16357-83-8(4-Aminopyrimidine-5-carbaldehyde)
• 89853-87-2(4-Amino-5-carboxy-2-ethylmercaptopyrimidine)
• 771-81-3(4-Amino-2-(methylthio)pyrimidine-5-carboxylic acid)
• 661450-77-7(5-Pyrimidinecarboxaldehyde, 4-amino-2-(butylthio)-)
• 185040-35-1(4-(Ethylamino)-2-(methylthio)pyrimidine-5-carbaldehyde)
• 185040-32-8(4-(methylamino)-2-methylsulfanyl-pyrimidine-5-carbaldehyde)
• 867353-54-6(5-Pyrimidinecarboxaldehyde, 4-amino-2-(ethylthio)-)
• 335318-29-1(4-amino-2-benzylsulfanyl-pyrimidine-5-carbaldehyde)
• 89533-28-8(4-Amino-2-(methylthio)pyrimidine-5-carboxamide)